Amanta Healthcare Ltd
Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products.[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/OP |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Capacity Utilization - LVP (excl. SteriPort) % ・Standalone data |
|
||||
| Capacity Utilization - SteriPort % ・Standalone data |
|||||
| Installed Capacity - SteriPort (LVP) Crore bottles per year ・Standalone data |
|||||
| Installed Capacity - SVP Crore bottles per year ・Standalone data |
|||||
| Active Export Countries count ・Standalone data |
|||||
| Product Portfolio count ・Standalone data |
|||||
| International Product Registration Jurisdictions count ・Standalone data |
|||||
| Number of Distributors & Stockists count ・Standalone data |
|||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
10h - Intimation of Schedule of the Earnings Conference Call for Q1 ended June 30, 2026
-
Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results For The Quarter Ended June 30, 2026
29 Jul - Board meets August 5, 2026 to approve Q1 FY2027 unaudited results; trading window reopens August 8.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
10 Jul - Submitted Regulation 74(5) depository certificate for quarter ended June 30, 2026.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
9 Jul - Amanta Healthcare held virtual investor meeting with ValPro Capital on July 9, 2026.
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 6 Jul
Concalls
-
May 2026Transcript PPT REC
-
Feb 2026Transcript PPT
Business Profile:[1][2]
Amanta Healthcare is a niche pharmaceutical company specializing in sterile liquid parenteral (injections and infusions) using ABFS and ISBM technologies. It operates across six therapeutic segments: fluid therapy, diluents and injectables, ophthalmic, respiratory solutions, irrigation, and other formulations.
As an integrated LVP and SVP manufacturer,
its products support critical care in oncology, pediatrics, ICU, and anesthesia. Under its “SteriPort” brand for two-port IV systems, management estimates a 50–60% domestic market share in PP IV bottles.